Gangstem Biotech to Engage in Technology Exchange at Bio Korea and BIO USA

[Asia Economy Reporter Chunhee Lee] Kangstem Biotech announced on the 17th that following its participation in the recently held 'BIO KOREA 2022,' it will participate in the '2022 BIO International Convention (BIO USA)' held next month in San Diego, USA, engaging in technology consultations and exchanges.

BIO KOREA 2022 was hosted by the Korea Health Industry Development Institute and took place over three days from the 11th to the 13th at COEX in Gangnam-gu, Seoul. Marking its 17th edition this year, it is the largest bio industry event in Korea. About 700 companies from 50 countries participated, with programs including conferences, exhibitions, and business open forums.

At this event, Kangstem Biotech introduced its main business pipelines such as stem cell therapeutics and organoids, and conducted technology consultations on cutting-edge stem cell applications, exchanging with domestic and international companies. The company was also selected as a presenting company at BIO LIVE, a business presentation event involving overseas companies and embassies, where it introduced the company and its overall business through a video presentation.

Subsequently, Kangstem Biotech plans to participate in BIO USA, held from the 13th to the 16th of next month in San Diego, USA. This is the 29th edition of the world's largest bio industry conference. Kangstem Biotech explained that partnering meetings with leading global companies have been confirmed for this event. The company plans to conduct one-on-one meetings with dozens of companies.

Seomyeong Kwan, Head of Business Development at Kangstem Biotech, said, “As various face-to-face activities have recently become more active, we are now able to engage in technology consultations and exchanges between companies offline. Starting with BIO KOREA, we will actively participate in upcoming bio events and conferences to promote our unique technologies and pipelines.”